Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | HBB | P68871 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30757517 | 0.89 | — | — | |
| SCHEMBL27939233 | 0.78 | MEN1 (0.65) | MEN1LMNABLMHBBKMT2A | |
| SCHEMBL27907610 | 0.76 | GAA (0.50) | MEN1LMNABLMHBBKMT2A | |
| SCHEMBL6073675 | 0.76 | ALDH1A1 (0.52) | MEN1LMNABLMHBBKMT2A | |
| SCHEMBL5593734 | 0.73 | — | — | |
| SCHEMBL15013922 | 0.72 | ALDH1A1 (0.56) | MEN1LMNABLMHBBKMT2A | |
| SCHEMBL93369 | 0.72 | — | — | |
| SCHEMBL451525 | 0.71 | TDP1 (0.50) | ALDH1A1TDP1TSHRHAO1 | |
| SCHEMBL10050986 | 0.70 | FAAH (0.52) | MEN1LMNABLMHBBKMT2A | |
| SCHEMBL9015855 | 0.69 | TDP1 (0.64) | MEN1KMT2AALDH1A1TDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7238820-B2 | Fluorine-free metallic complexes for gas-phase chemical metal deposition | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2007-07-03 | — | — | US | disclosed |
| EP-1551851-B1 | FLUORINE-FREE METALLIC COMPLEXES FOR GAS-PHASE CHEMICAL METAL DEPOSITION | CENTRE NAT RECH SCIENT (FR) | 2006-08-02 | — | — | EP | disclosed |
| US-20060121709-A1 | Fluorine-free metallic complexes for gas-phase chemical metal deposition | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2006-06-08 | — | — | US | disclosed |
| EP-1551851-A1 | FLUORINE-FREE METALLIC COMPLEXES FOR GAS-PHASE CHEMICAL METAL DEPOSITION | Centre National De La Recherche Scientifique (FR) | 2005-07-13 | — | — | EP | disclosed |
| WO-2004029061-A1 | FLUORINE-FREE METALLIC COMPLEXES FOR GAS-PHASE CHEMICAL METAL DEPOSITION | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2004-04-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060121709-A1 | Fluorine-free metallic complexes for gas-phase chemical metal deposition | SOD1, FUS, AFF2 | MEN1 1252/4885LMNA 4226/4885BLM 1260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.